[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-13227":3,"doc-seo-13227":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},13227,1099513958762,"Logic","https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?_k=1776737595927829259",8,"Research & Report","Design, Formulation, In Vitro and In Vivo Pharmacokinetic Evaluation of Nicardipine Nanostructured Lipid Carrier for Transdermal Drug Delivery System","Nanostructured lipid carriers (NLCs) were developed to enhance transdermal delivery of nicardipine hydrochloride (NCP), addressing barriers such as poor solubility, limited bioavailability, and stratum corneum resistance. The study used response surface methodology with Box–Behnken design to optimize formulation, evaluating shape, in vitro release, in vivo absorption, and skin contact properties. An HPLC method was employed for analysis using a C18 column and specified instrumentation.","cbCaigUBuzuhsbHO","https://ap.wps.com/l/cbCaigUBuzuhsbHO","pdf",3470948,13,1,14,"English","en","",1776554137,35,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":23,"slug":31,"title":13,"keywords":24,"description":14,"schema_data":32,"social_meta":67,"head_meta":70,"extra_data":72,"updated_unix":25},105,"design-formulation-in-vitro-and-in-vivo-pharmacokinetic-evaluation-of-nicardipine-nanostructured-lipid-carrier-for-transdermal-drug-delivery-system",{"@graph":33,"@context":66},[34,51],{"@type":35,"itemListElement":36},"BreadcrumbList",[37,41,45,48],{"item":38,"name":39,"@type":40,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":42,"name":43,"@type":40,"position":44},"https://docshare.wps.com/document/","Document",2,{"item":46,"name":12,"@type":40,"position":47},"https://docshare.wps.com/document/research-report/",3,{"item":49,"name":13,"@type":40,"position":50},"https://docshare.wps.com/document/design-formulation-in-vitro-and-in-vivo-pharmacokinetic-evaluation-of-nicardipine-nanostructured-lipid-carrier-for-transdermal-drug-delivery-system/13227/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"description":14,"dateModified":59,"datePublished":60,"encodingFormat":58,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":38,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-06-05","2026-04-18",true,{"@type":63,"interactionType":64,"userInteractionCount":19},"InteractionCounter",{"@type":65},"ViewAction","https://schema.org",{"og:url":68,"og:type":69,"og:title":13,"og:site_name":56,"og:description":14},"https://docshare.wps.com/document/design-formulation-in-vitro-and-in-vivo-pharmacokinetic-evaluation-of-nicardipine-nanostructured-lipid-carrier-for-transdermal-drug-delivery-system/13227","article",{"robots":71,"canonical":68},"index,follow",{"doc_id":7,"site_id":30}]